VIVEbiotech

VIVEbiotech is a GMP CDMO fully focused on the development and GMP manufacture of lentiviral vectors from very early stages to GMP. Being fully focused on customers´projects, VIVEbiotech adapts to their requirements being highly flexible in terms of technical adaptation and slots availability.

VIVEbiotech is currently working for clients based in Europe, USA and Asia, manufacturing lentiviral vectors for different applications such as rare diseases as well as immune-oncology (CAR-Ts, TCRs, CAR-NKs, TILs), among others.

One of VIVEbiotech´s main features is its specialization in virology. Based on it, the R&D department is focusing its efforts on the development of more cost-effective processes and safer lentiviral vectors (worldwide patented technology called Lentisoma).